immune repertoire sequencing China's Singleron Biotechnologies Pushes Single-Cell RNA-seq Into Clinical, Translational Studies Premium The company, founded by a Qiagen veteran and a Yale professor, offers a complete single-cell transcriptomics workflow, from sample preservation to data analysis. Adaptive Biotech Touts Progress Toward Lyme and Gastrointestinal Disease Diagnostics Premium The firm is expanding its plans from a Crohn's disease test to a broader GI differential diagnostic and continues to expect to launch its Lyme disease assay by year-end. Adaptive Biotechnologies Q1 Revenues up 84 Percent, Beat Analyst Estimates The company attributed its $38.4 million in quarterly revenues to strong progress in both the sequencing and development services arms of its business. Enpicom, Viroclinics-DDL Expand Partnership to Accelerate Antibody, Vaccine Discovery A Dutch province has awarded an unspecified sum to the Netherlands-based firms to combine their technologies for TCR and BCR repertoire sequencing and analysis. Personalis Q4 Revenues up 11 Percent The genomics company reported revenues of $20.2 million for the quarter, driven by growth in its pharmaceutical services business and other non-VA customers. Feb 25, 2021 Adaptive Biotechnologies Touts New Era of T Cell-Based Dx With T-Detect COVID Launch Premium Feb 25, 2021 10x Genomics Acquires Denmark's Tetramer Shop Feb 24, 2021 Adaptive Biotechnologies Q4 Revenues Rise 25 Percent Feb 23, 2021 Adaptive Biotechnologies, LabCorp Expand Collaboration Jan 11, 2021 Adaptive Biotechnologies, AstraZeneca Collaborate on Mapping Immune Response in Cancer Jan 4, 2021 Enpicom Sees Personalized Medicine Coming Into Focus After Busy 2020 Premium Dec 23, 2020 Personalis Sees New Neoantigen Platform Driving Improved Immunotherapy Prediction Premium Dec 21, 2020 Adaptive Biotechnologies, Q2 Solutions Sign Marketing Agreement for ImmunoSeq Assay Dec 15, 2020 Enpicom, MiLaboratories Partner on Immune Repertoire Sequencing Software Integration Nov 11, 2020 Adaptive Biotechnologies Prepares to Launch T Cell-Based COVID-19 Test Premium Nov 10, 2020 Adaptive Biotechnologies Q3 Revenues Grow 1 Percent Oct 7, 2020 Immunotherapy Response Prediction Improved by Baseline, On-Treatment Biomarker Combo Premium Sep 9, 2020 Adaptive Biotechnologies, Takara Bio T Cell Receptor Sequencing Methods Rank High in Benchmarking Study Premium Aug 21, 2020 Single-Cell Analysis Reveals Ulcerative Colitis Tissue, Immune Features Aug 10, 2020 Adaptive Biotechnologies Q2 Revenues Fall 5 Percent, Beat Analyst Estimates Aug 10, 2020 T Cell Receptor Repertoire Linked to Anti-PD-1 Therapy Response in Hodgkin Lymphoma Jul 16, 2020 Adaptive Biotechnologies to Raise $240M in Public Stock Offering May 21, 2020 Genomic, Synthetic Bio Platforms Power COVID-19 Antibody Discovery at Vanderbilt Lab Premium May 13, 2020 Adaptive Eyes NGS-Based Test for T Cell Response in COVID-19 Premium May 12, 2020 Adaptive Biotechnologies Q1 Revenues Grow 65 Percent Load More Breaking News Pacific Biosciences, Rady Children's Collaborate on Study of WGS-Based Rare Disease Dx Codex DNA Closes $122.7M IPO Infinity BiologiX to Offer Cytox Alzheimer's Disease Genetic Risk Test in US Archaic Hominin History, Interactions Revealed With Denisova Cave Sediment Sequences Liquid Biopsy Startup Adela Launches With $60M Series A Financing Round Genomic Testing Cooperative's Hematologic Neoplasms, Solid Tumor Tests Receive NY State Approval, Medicare Coverage The Scan NFTs for Genome Sharing Nature News writes that non-fungible tokens could be a way for people to profit from sharing genomic data. Wastewater Warning System Time magazine writes that cities and college campuses are monitoring sewage for SARS-CoV-2, an approach officials hope lasts beyond COVID-19. Networks to Boost Surveillance Scientific American writes that new organizations and networks aim to improve the ability of developing countries to conduct SARS-CoV-2 genomic surveillance. Genome Biology Papers on Gastric Cancer Epimutations, BUTTERFLY, GUNC Tool In Genome Biology this week: recurrent epigenetic mutations in gastric cancer, correction tool for unique molecular identifier-based assays, and more.